EVALUATED EFFECTS OF THE TREATMENT WITH IMATINIB OF CHRONIC MYELOID LEUKEMIA PATIENTS WITH ADDITIONAL CYTOGENETIC ABNORMALITIES IN HEMATOLOGY AND BLOOD TRANSFUTION CENTER, BACHMAI HOSPITAL. YHCĐ [Internet]. 2026 Mar. 2 [cited 2026 Sept. 8];67(2). Available from: https://tapchiyhcd.vn/index.php/yhcd/article/view/4337